If you are, or if you are close to someone with advanced non-small cell lung cancer who is 18 years of age or older and can take care of his or her own diet, you can follow this new drug clinical trial with registration number CTR20191957.
The trial is led by Professor Yilong Wu of Guangdong Provincial People's Hospital as the principal investigator, who leads and participates in the development of the new drug and the treatment of patients.
There is no control group in the trial. All patients who successfully apply and participate in the trial will be treated with the new drug, Beritinib capsules, and all drugs used during treatment will be provided free of charge to patients by the project team, and patients will not have to pay any treatment costs.
The following 19 hospitals participated in this clinical trial and provided treatment to the enrolled patients.
Eighty patients have successfully applied for enrollment in the trial, with 105 spots remaining. Depending on your actual situation, you can consider enrolling in the trial and receiving treatment near you.
The tests, examinations and treatments are conducted at these major tertiary hospitals and the clinical trials are approved by the state and are legal and compliant.
If you have such a cancer patient around you, you can forward it to them as you wish, it may save someone's life.
If you are still unclear, you can click on my avatar above to send me a private message.
Project registration number: CTR20191957
